- Home
- NYT vs RGC Comparison
NYT vs RGC Comparison
Compare NYT & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NYT | RGC |
|---|---|---|
| Founded | 1851 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Newspapers/Magazines | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 11.5B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NYT | RGC |
|---|---|---|
| Price | $74.51 | $28.63 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $72.14 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 90.1K |
| Earning Date | 05-06-2026 | 10-31-2025 |
| Dividend Yield | ★ 1.16% | N/A |
| EPS Growth | ★ 18.08 | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $1,783,639,000.00 | N/A |
| Revenue This Year | $10.58 | N/A |
| Revenue Next Year | $6.98 | N/A |
| P/E Ratio | $139.19 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $51.03 | $9.39 |
| 52 Week High | $87.10 | $950.00 |
Technical Indicators
Market Signals| Indicator | NYT | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 36.61 | 51.34 |
| Support Level | $69.30 | $25.41 |
| Resistance Level | $86.57 | $29.26 |
| Average True Range (ATR) | 2.39 | 2.18 |
| MACD | -0.49 | -0.17 |
| Stochastic Oscillator | 0.51 | 47.88 |
Price Performance
Historical ComparisonAbout NYT New York Times Company (The)
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.